Quarterly Results

  • Company Name :
Lupin Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500257
  • NSE Symbol:
  • LUPIN
  • P/E(TTM):
  • 33.30
  • ISIN Demat:
  • INE326A01037
  • Div & Yield%:
  • 0.37
  • EPS(TTM):
  • 65.66
  • Book Value(₹):
  • 481.70
  • Market Cap(₹Cr.):
  • 99,816.42
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars September 2024 ( Cr)June 2024 ( Cr)March 2024 ( Cr)
Gross Sales 3,931.73 4,084.00 3,331.72
Excise Duty 0.00 0.00 0.00
Net Sales 3,931.73 4,084.00 3,331.72
Other Operating Income 174.47 83.63 64.16
Other Income 32.62 38.22 31.34
Total Income 4,138.82 4,205.85 3,427.22
Total Expenditure 2,991.45 2,967.96 2,695.53
PBIDT 1,147.37 1,237.89 731.69
Interest 17.55 13.55 13.49
PBDT 1,129.82 1,224.34 718.20
Depreciation 145.77 141.42 290.04
Tax 171.95 189.19 69.06
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 4.34 4.55 -24.98
Reported Profit After Tax 807.76 889.18 384.08
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 807.76 889.18 384.08
EPS (Unit Curr.) 17.71 19.51 8.43
EPS (Adj) (Unit Curr.) 17.71 19.51 8.43
Calculated EPS (Unit Curr.) 17.71 19.50 8.43
Calculated EPS (Adj) (Unit Curr.) 17.71 19.50 8.43
Calculated EPS (Ann.) (Unit Curr.) 70.83 78.01 33.71
Calculated EPS (Adj) (Ann.) (Unit Curr.) 70.83 78.01 33.71
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 91.23 91.19 91.14
Reserve & Surplus 21,887.03 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 29.18 30.31 21.96
PBDTM(%) 28.74 29.98 21.56
PATM(%) 20.54 21.77 11.53